Invention Grant
- Patent Title: Cancer antigen peptides derived from WT1
- Patent Title (中): 衍生自WT1的癌抗原肽
-
Application No.: US12554151Application Date: 2009-09-04
-
Publication No.: US08388975B2Publication Date: 2013-03-05
- Inventor: Haruo Sugiyama
- Applicant: Haruo Sugiyama
- Applicant Address: JP Suita-shi
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Suita-shi
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2004-105219 20040331
- Main IPC: A61K39/00
- IPC: A61K39/00
Abstract:
The present invention relates to HLA-A26-binding cancer antigen peptides derived from WT1, polynucleotides encoding said peptide, CTL-inducers, and cancer vaccine comprising said peptide or polynucleotide.
Public/Granted literature
- US20100062013A1 CANCER ANTIGEN PEPTIDES DERIVED FROM WT1 Public/Granted day:2010-03-11
Information query
